Developing and validating COVID-19 adverse outcome risk prediction models from a bi-national European cohort of 5594 patients
Developing and validating COVID-19 adverse outcome risk prediction models from a bi-national European cohort of 5594 patients is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Developing and validating COVID-19 adverse outcome risk prediction models from a bi-national European cohort of 5594 patients have?
Developing and validating COVID-19 adverse outcome risk prediction models from a bi-national European cohort of 5594 patients has 86 citations in the OpenAlex counts ScholarIQ stores.
When was Developing and validating COVID-19 adverse outcome risk prediction models from a bi-national European cohort of 5594 patients published?
Developing and validating COVID-19 adverse outcome risk prediction models from a bi-national European cohort of 5594 patients has 2021 year in the ScholarIQ index.
What is the open-access status of Developing and validating COVID-19 adverse outcome risk prediction models from a bi-national European cohort of 5594 patients?
Developing and validating COVID-19 adverse outcome risk prediction models from a bi-national European cohort of 5594 patients has gold oa status in the ScholarIQ index.
What is the DOI of Developing and validating COVID-19 adverse outcome risk prediction models from a bi-national European cohort of 5594 patients?
The DOI for Developing and validating COVID-19 adverse outcome risk prediction models from a bi-national European cohort of 5594 patients is on the source record.
What is the PMID of Developing and validating COVID-19 adverse outcome risk prediction models from a bi-national European cohort of 5594 patients?
The PMID for Developing and validating COVID-19 adverse outcome risk prediction models from a bi-national European cohort of 5594 patients is on the source record.
What is the OpenAlex record for Developing and validating COVID-19 adverse outcome risk prediction models from a bi-national European cohort of 5594 patients?
The OpenAlex for Developing and validating COVID-19 adverse outcome risk prediction models from a bi-national European cohort of 5594 patients is on the source record.